期刊文献+

阿奇霉素在心血管疾病患者中合理性应用策略 被引量:4

Reasonable use of azithromycin in treatment of patients with cardiovascular disease
原文传递
导出
摘要 目的探讨在心血管疾病患者中如何安全、合理的使用阿奇霉素,为临床用药提供指导。方法对1例使用阿奇霉素后发生QT间期延长的扩张型心肌病给予停用的患者进行分析,并查阅医院心血管内科2012年8月-2013年7月所有住院患者静脉滴注阿奇霉素的资料,分析其用药合理性。结果停用阿奇霉素后2d,患者未再发作心悸,复查心电图QT间期恢复正常;医院心血管内科使用阿奇霉素共24例,根据合并基础疾病情况20.8%的使用合理、79.2%使用不合理;24例中的高龄患者占33.3%;疗程>5d的占91.7%。结论阿奇霉素抗感染治疗时应注意选择合适的人群,给予恰当的疗程,关注电解质平衡,避免药物相互作用引起的不良反应的增加,摒弃与喹诺酮类药物的联合方案。 OBJECTIVE To explore the use of azithromycin for treatment of the patients with cardiovascular disease in reasonable and safe way so as to provide guidance for clinical use of antibiotics.METHODS A patient with dilat-ed cardiomyopathy at prolonged QT interval,who was treated with azithromycin,was enrolled in the study,then the clinical data of all the patients who were hospitalized the department of cardiovascular medicine for intravenous administration of azithromycin from Aug 2012 to Jul 2013 were reviewed,and the rationality of use of antibiotics was analyzed.RESULTS The patients did not have episodes of palpitations and the electrocardiogram at QT interval returned to normal after discontinuation of azithromycin for two days.Totally 24 patients in the department of car-diovascular medicine used azitromycin,among whom 20.8% used reasonably and 79.2% did not use reasonably, according to the condition of underlying diseases;the elderly patients accounted for 33.3% (24 cases);the pa-tients with the treatment course more than 5 days accounted for 9 1 .7%.CONCLUSION As azithromycin is pre-scribed for anti-infection treatment,it is necessary to pay attention to the choice of targeted population,give ap-propriate treatment course,focus on electrolyte balance,avoid increase of adverse events induced by interactions of drugs,and abandon combination drug therapy with quinolones.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第1期96-98,共3页 Chinese Journal of Nosocomiology
基金 河南省教育厅科学技术研究重点基金项目(13A350851)
关键词 阿奇霉素 QT间期延长 致死性心律失常 合理性 Azithromycin Prolonged QT interval Lethal arrhythmia Rationality
  • 相关文献

参考文献5

  • 1Sanguinetti MC,Tristani-Firouzi M.hERG potassium channels and cardiac arrhythmia[J].Nature,2006,440(7083):463-469.
  • 2苏平菊,王岳.阿奇霉素药理毒理研究进展[J].现代中西医结合杂志,2008,17(8):1295-1296. 被引量:31
  • 3Ray WA,Murray KT,Meredith S,et al.Oral erythromycin and the risk of sudden death from cardiac causes[J].N Engl J Med,2004,351(11):1089-1096.
  • 4Svanstrom H,Pasternak B,Hviid A.Use of azithromycin and death from cardiovascular causes[J].N Engl J Med,2013,368(18):1704-1712.
  • 5Dresser GK,Spence JD,Bailey DG.Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4inhibition[J].Clin Pharmacokinet,2000,38(1):41-57.

二级参考文献7

共引文献30

同被引文献25

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部